Inhibition of Trypanosoma cruzi proline racemase affects host-parasite interactions and the outcome of in vitro infection

Memorias do Instituto Oswaldo Cruz

Volumn 104, Issue 8, 2009, Pages 1055-1062

  Coutinho, Leticia ^a,b   Ferreira, Marcelo Alves ^a   Cosson, Alain ^c   Batista, Marcos Meuser ^b   Batista, Denise da Gama Jaén ^b   Minoprio, Paola ^c   Degrave, Wim M ^a   Berneman, Armand ^c   Soeiro, Maria de Nazaré Correia ^b  

^a Funcional e Bioinformática   (Spain)

^b INSTITUTO OSWALDO CRUZ   (Brazil)

^c INSTITUT PASTEUR   (France)

Author keywords

Enzyme inhibition; Host parasite interaction; Proline racemase; Trypanosoma cruzi

Indexed keywords

TRYPANOSOMA CRUZI;

EID: 72449134851     PISSN: 00740276     EISSN: 16788060     Source Type: Journal    
DOI: 10.1590/S0074-02762009000800001     Document Type: Article

References (30)

1. Araujo-Jorge TC, Sampaio EP, De Souza W, Meirelles MN 1989. Trypanosoma cruzi: the effect of variations in experimental conditions on the levels of macrophage infection in vitro. Parasitol Res 75: 257-263.
2. Bilate AM, Teixeira PC, Ribeiro SP, Brito T, Silva AM, Russo M, Kalil J, Cunha-Neto E 2008. Distinct outcomes of Trypanosoma cruzi infection in hamsters are related to myocardial parasitism, cytokine/chemokine gene expression and protein expression profile. J Infect Dis 198: 614-623.
3. Buschiazzo A, Goytia M, Schaeffer F, Degrave W, Shepard W, Gregoire C, Chamond N, Cosson A, Berneman A, Coatnoan N, Alzari PM, Minoprio P 2006. Crystal structure, catalytic mechanism and mitogenic properties of Trypanosoma cruzi proline racemase. Proc Natl Acad Sci USA 103: 1705-1710.
4. Chamond N, Goytia M, Coatnoan N, Barale JC, Cosson A, Degrave WM, Minoprio P 2005. Trypanosoma cruzi proline racemases are involved in parasite differentiation and infectivity. Mol Microbiol 58: 46-60.
5. Chamond N, Gregoire C, Coatnoan N, Rougeot C, Freitas-Junior LH, Da Silveira JF, Degrave WM, Minoprio P 2003. Biochemical characterization of proline racemases from the human protozoan parasite Trypanosoma cruzi and definition of putative protein signatures. J Biol Chem 278: 15484-15494.
6. Coatnoan N, Berneman A, Chamond N, Minoprio P 2009. Proline racemases: insights into Trypanosoma cruzi peptides containing D-proline. Mem Inst Oswaldo Cruz 104 (Suppl.): 295-300.
7. Coura JR, Junqueira AC, Fernandes O, Valente AS, Miles MA 2002. Emerging Chagas disease in Amazonian Brazil. Trends Parasitol 18: 171-176.
8. Covarrubias C, Cortez M, Ferreira D, Yoshida N 2007. Interaction with host factors exacerbates Trypanosoma cruzi cell invasion capacity upon oral infection. Int J Parasitol 37: 1609-1616.
9. Da Silva CF, Batista MM, Batista DG, De Souza EM, Da Silva PB, De Oliveira GM, Meuser AS, Shareef AR, Boykin DW, Soeiro MN 2008. In vitro and in vivo studies of the trypanocidal activity of a diarylthiophene diamidine against Trypanosoma cruzi. Antimicrob Agents Chemother 52: 3307-3314.
10. De Souza EM, Araujo-Jorge TC, Bailly C, Lansiaux A, Batista MM, Oliveira GM, Soeiro MN 2003. Host and parasite apoptosis following Trypanosoma cruzi infection in in vitro and in vivo models. Cell Tissue Res 314: 223-235.
11. De Souza VA, Da Silva R, Pereira AC, Royo VA, Saraiva J, Montanheiro M, De Souza GH, Da Silva Filho AA, Grando MD, Donate PM, Bastos JK, Albuquerque S, Silva ML 2005. Trypanocidal activity of (-)-cubebin derivatives against free amastigote forms of Trypanosoma cruzi. Bioorg Med Chem Lett 15: 303-307.
12. De Souza W 2008. Electron microscopy of trypanosomes - a historical view. Mem Inst Oswaldo Cruz 103: 313-325.
13. Dias JC 2006. Chagas disease: successes and challenges. Cad Saude Publica 22: 2020-2021.
14. Dias JC 2007. Globalization, inequity and Chagas disease. Cad Saude Publica 23 (Suppl. 1): S13-22.
15. Fernandes MC, Cortez M, Geraldo-Yoneyama KA, Straus AH, Yoshida N, Mortara RA 2007. Novel strategy in Trypanosoma cruzi cell invasion: implication of cholesterol and host cell microdomains. Int J Parasitol 37: 1431-1441.
16. Herrera EM, Ming M, Ortega-Barria E, Pereira ME 1994. Mediation of Trypanosoma cruzi invasion by heparan sulfate receptors on host cells and penetrin counter-receptors on the trypanosomes. Mol Biochem Parasitol 65: 73-83.
17. Hespanhol RC, de Nazaré C Soeiro M, Meuser MB, de Nazareth SL, Meirelles M, Côrte-Real S. 2005. The expression of mannose receptors in skin fibroblast and their involvement in Leishmania (L.) amazonensis invasion. J Histochem Cytochem 53: 35-44.
18. Marin-Neto JA, Rassi AJR, Morillo CA, Avezum A, Connolly SJ, Sosa-Estani S, Rosas F, Yusuf S 2008. Rationale and design of a randomized placebo-controlled trial assessing the effects of etiologic treatment in Chagas cardiomyopathy: the benznidazole evaluation for interrupting trypanosomiasis (BENEFIT). Am Heart J 156: 37-43.
19. Minoprio P 2001. Parasite polyclonal activators: new targets for vaccination approaches? Int J Parasitol 31: 588-591.
20. Moro A, Ruiz-Cabello F, Fernandez-Cano A, Stock RP, Gonzalez A 1995. Secretion by Trypanosoma cruzi of a peptidyl-prolyl cistrans isomerase involved in cell infection. EMBO J 14: 2483-2490.
21. Ortega-Barria E, Pereira ME 1991. A novel T. cruzi heparin-binding protein promotes fibroblast adhesion and penetration of engineered bacteria and trypanosomes into mammalian cells. Cell 67: 411-421.
22. Reina-San-Martin B, Degrave W, Rougeot C, Cosson A, Chamond N, Cordeiro-Da-Silva A, Arala-Chaves M, Coutinho A, Minoprio P 2000. A B-cell mitogen from a pathogenic trypanosome is a eukaryotic proline racemase. Nat Med 6: 890-897.
23. Rocha MO, Teixeira MM, Ribeiro AL 2007. An update on the management of Chagas cardiomyopathy. Expert Rev Anti Infect Ther 5: 727-743.
24. Rosestolato CT, Dutra JM, De Souza W, De Carvalho TM 2002. Participation of host cell actin filaments during interaction of trypomastigote forms of Trypanosoma cruzi with host cells. Cell Struct Funct 27: 91-98.
25. Schmunis GA 2007. Epidemiology of Chagas disease in non-endemic countries: the role of international migration. Mem Inst Oswaldo Cruz 102 (Suppl. I): 75-85.
26. Tarleton RL 2007. Immune system recognition of Trypanosoma cruzi. Curr Opin Immunol 19: 430-434.
27. Villalta F, Madison MN, Kleshchenko YY, Nde PN, Lima MF 2008. Molecular analysis of early host cell infection by Trypanosoma cruzi. Front Biosci 13: 3714-3734.
28. Woolsey AM, Sunwoo L, Petersen CA, Brachmann SM, Cantley LC, Burleigh BA 2003. Novel PI 3-kinase-dependent mechanisms of trypanosome invasion and vacuole maturation. J Cell Sci 116: 3611-3622.
29. Yoshida N 2006. Molecular basis of mammalian cell invasion by Trypanosoma cruzi. An Acad Bras Cienc 78: 87-111.
30. Yoshida N, Cortez M 2008. Trypanosoma cruzi: parasite and host cell signaling during the invasion process. Subcell Biochem 47: 82-91.